FINANCIAL RELEASES

TEMPE, Ariz. --(BUSINESS WIRE)--Oct. 1, 2025-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q2'25 total revenues were $1,012.4 million , up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million , or 2.7% sequentially, and favorably impacted by approximately $5.6 million , or 0.6% year-over-year (1)

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 1, 2025-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Celebrates the 20 million Invisalign ® patient "Smilestone" and thanks the more than 280 thousand Invisalign ® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2%

TEMPE, Ariz. --(BUSINESS WIRE)--Apr. 1, 2025-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively Q4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year Q4 Systems and Services revenues up 5.2% sequentially,

TEMPE, Ariz. --(BUSINESS WIRE)--Jan. 2, 2025-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Company expects to repurchase up to $275.0 million of its common stock beginning in Q4'24 Q3'24 total revenues of $977.9 million , increased 1.8% year-over-year, and Q3'24 diluted net income per share was $1.55 , or $2.35 on a non-GAAP diluted basis Q3'24 total revenues were unfavorably impacted by

TEMPE, Ariz. --(BUSINESS WIRE)--Oct. 2, 2024-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Total Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids Q2'24 total revenues of $1,028.5 million , increased 3.1% sequentially, and increased 2.6% year-over-year, and Q2'24 diluted net income per share was $1.28 , or $2.41 on a non-GAAP diluted basis Q2'24

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 2, 2024-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q1 ' 24 total revenues up 5.8% year-over-year including revenue growth of 3.5% from Clear Aligners and growth of 17.5% from Imaging Systems and CAD/CAM Services Q1'24 total revenues of $997.4 million , increased 5.8% year-over-year, and diluted net income per share of $1.39 , non-GAAP diluted net

TEMPE, Ariz. --(BUSINESS WIRE)--Apr. 1, 2024-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Unveils Next-Generation iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture 1 in a 50% Smaller Wand 2 that Delivers Faster Scanning, Higher Accuracy 3 , and Superior Visualization 4 for Greater Practice Efficiency Q4 and FY2023 total revenues up 6.1% year over year and up 3.4%

TEMPE, Ariz. --(BUSINESS WIRE)--Jan. 2, 2024-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q3’23 record clear aligner shipments to teenage patients increased 9.9% sequentially and 8.4% year over year, driven by continued strength from Invisalign First™ Company expects to repurchase up to $250.0 million of its common stock in Q4’23 Q3'23 total revenues of $960.2 million , increased 7.8%

TEMPE, Ariz. --(BUSINESS WIRE)--Oct. 4, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Better than expected revenues and operating margins reflect improving trends across regions Q2’23 Clear Aligner cases for teenagers increased 7% sequentially and 10% year over year, driven by momentum in both Submitters and Utilization and continued growth from Invisalign First™ Q2'23 total

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Delivers revenue and EPS ahead of expectations, with total Invisalign® patients treated surpassing 15 million globally Completes May 13, 2021   $1 Billion Stock Repurchase Program Q1'23 total revenues of $943.1 million , increased 4.6% sequentially, and diluted net income per share of $1.14 ,